Merck/Schering-Plough Pharmaceuticals
Press Releases
Information About the SEAS Study
Information About the ENHANCE Trial
Frequently Asked Questions
Home
About Us
Patient Assistance Program
Responsibility and Compliance
Company News
MERCK/Schering-Plough Pharmaceuticals

About Us

Merck/Schering-Plough Pharmaceuticals was formed to develop and market new prescription medicines in cholesterol management.

Merck/Schering-Plough currently offers 2 medicines for cholesterol management: VYTORIN® (ezetimibe/simvastatin) and ZETIA® (ezetimibe).

Our Companies

Merck/Schering-Plough Pharmaceuticals is a joint venture between Merck & Co., Inc., and Schering-Plough Corporation. The collaboration includes worldwide markets (excluding Japan).

Merck & Co., Inc., is a global research-driven pharmaceutical company dedicated to putting patients first. Merck discovers, develops, manufactures, and markets vaccines and medicines in over 20 therapeutic categories and publishes unbiased health information as a not-for-profit service. For more information, visit merck.com.

Schering-Plough is a global science-based health care company that aspires to earn the trust of doctors, patients, and customers by providing a steady flow of innovative medicines and services that improve the health and well-being of people around the world. For more information, visit schering-plough.com.